Blood pressure and dementia risk share surprising link, study suggests

In a large, randomized trial, researchers led by First Hospital of China Medical University discovered that "intensive blood pressure control" resulted in a 15% reduced dementia risk among participants and a 16% reduced risk of cognitive impairment.

The study included 33,995 people in rural China aged 40 or older who had "uncontrolled hypertension."

The participants were divided into two groups. One received "usual care," while the other was assigned to "trained non-physician community healthcare providers" who prescribed "titrated antihypertensive medications."

For the latter group, the medications helped them achieve a systolic blood pressure goal of <130 mm Hg and a diastolic blood pressure goal of <80 mm Hg, according to the study findings in Nature Medicine.

They were also less likely to experience "serious adverse events."

This was one of the first large-scale, randomized, controlled effectiveness trials to demonstrate a "significant reduction in all-cause dementia associated with lowering blood pressure," the researchers concluded.

"Unlike studies performed in the United States, this study employed non-physicians to significantly reduce blood pressure in rural China through a 'cluster' blinding method," Serwer, who was not involved in the study, told Fox News Digital.

"While the study can be subject to scrutiny, it raises a pertinent question: How crucial is modification of cardiovascular risk factors in the development of dementia?"

"These commonly prescribed medications have been independently associated with a reduced risk of dementia, irrespective of the magnitude of blood pressure reduction they achieve," he said.

"This raises the possibility that the lower rates of dementia observed may be attributed to other beneficial effects of the medications rather than solely to blood pressure reduction."

To confirm the findings, Serwer said it would be beneficial to include baseline cognitive assessments of the patients and to identify the prevalence of Alzheimer's dementia within the communities.

The study was supported by the National Key Research and Development Program of the Ministry of Science and Technology of China, Chinese Society of Cardiology Foundation, and the Science and Technology Program of Liaoning Province, China.

Fox News Digital reached out to the researchers for comment.